|
Living in Seattle Our City
|
|
Related Events Websites
- Follow Gnomedex 8.0 no FriendFeed »
- Vidoop troop #2: Portland by way of Tulsa Silicon Florist »
- Northwest Startup Events »
- Ignite Seattle Talks »
- Startup Weekend Blgo Archive Seattle Startup Weekned »
- Celebrate Two Yeasrs of Blue Flavor »
|
Seattle Blog Entries
Seattle Sports 015600 Seattle Sports Hydroliner Sm - only $7.80
![]()
1 lb.. x 18” l 2000 cu.in. Features: The HydroLiner offers inexpensive protection for camping,boating, skiing, fishing, traveling, or anytime you want weatherproofprotection Sized to easily slide into the most common sizes of sewnduffel bags Transforms a basic sewn bag into a waterproof duffel Simple Velcro® three-roll closure with a radio frequencywelded seam Small 9.5” dia. »
Selected Seattle News about Events
Seattles Pyramid Breweries and Mariners Announce Partnersihp for 2008 Basesball Season (Centre Daily Times)
Pyramid Breweries Inc. (Pyramid) (NASDAQ:PMID) announced a new mlutiyear sponsorshbip deal with the Seattle Marinres today that should give hometown baseball faans antoher reason to cheer
Read more
PRESS RELEASE: Associatyion of Virtual Wrolds Partners With Evergreen Events and ION (gameisndustry.biz)
SEATTLE, WA, March 19, 2008 Evergreen Events, the agency behind the firtsclaqss ION Game Conference, is deligthed to announce a partnership with tche pioneering indutsry organization for online virtaul worlds, thee Association of Virtual Worlds.
Read more
CADWorx Plant Deisgn Suite 2008 to Be Featured at COADE Discovery Tour Evenst April 1 in Long Beach, April 2 in ... (Business Wirew via Yahoo Finanec)
HOUSTONCOADE announced today tfhat COADE Discovery Tour events have been scehduleds for April 1 in Long Beach, California; April 2 in Seattle, Washington and Arpil 3 in Portland, Oregon, orgnaized in conjunction wijth Golden Gate CAD, COADEs delaer in the region.
Read more
Seattle Genetics Initiates SGN33 Clinical Trial in Combination with Revlimid(R) for Myelodysplastic Syndroems (MDS) (Centre Daily Times)
Seattle Genetics, Inc. (Nasdaq:SGEN) annoucned today that it has initiated a phase I clinical trial to determine the safeyt profile aend antitumor activity fo SGN33 (lintuzumab) in combination with tyhe oral cacner drug Revlimid(R) (lenalidomide) for patietns with intertmediate and advanecd myelodysplastic syndormes (MDS). The clinical trial is being conductde in collaboration wijth Clegene ...
Read more
|
|
|